nach oben

Erschienen in:

2022 | OriginalPaper | Buchkapitel

Re-Emerging Systemic Mucormycosis Associated With COVID-19 Infection in Africa

verfasst von : Abimbola D. Akinyosoye, Paul A. Akinduti

Erschienen in: Bioenergy and Biochemical Processing Technologies

Verlag: Springer International Publishing

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Mucormycosis (MM) is an invasive fungal infection that causes severe systemic infections and poses health risks and threat to life. Despite its impact on human health, MM infection is neglected and underrepresented compared to other infections. Invasiveness of MM severely compromises systemic and metabolic functions of the hepatic system, degeneration of lungs, trachea, and alveoli epithelial cell with increased fatality rate, and associated risk with therapeutic use of glucocorticoids in COVID-19. In Africa, the prevalence rate remains unknown due to late prognosis and non-reportability of the disease. Hence, there is a need to include MM diagnosis in patients with COVID-19, increase surveillance of emerging clonal strains, and regulate the routine glucocorticoids use in COVID-19 infection therapy.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Vorheriges Kapitel Microbial Quality of Watermelons Sold in Ota

Nächstes Kapitel Evaluation of Preservative and Shelf-Life Quality of Probiotic-Lactobacilli Fortified Nigerian Fermented Condiments

Adam S, Grecian S, Syed AA. (2016). Hereditary haemochromatosis presenting with diabetic ketoacidosis. QJM-Int J Med. 109(11),747-748.CrossRef

Afroz F, Barai L, Rahim MA, Kanta SS, Hossain MD. (2021). Post-COVID Pulmonary Mucormycosis: first case report from Bangladesh. Bangladesh j. med. sci. 32(2):156-160CrossRef

Alqarihi A, Gebremariam T, Gu Y, Swidergall M, Alkhazraji S, Soliman SS, Bruno VM, Edwards Jr JE, Filler SG, Uppuluri P, Ibrahim AS (2020). GRP78 and integrins play different roles in host cell invasion during mucormycosis. Mbio, 11(3):01087-20.CrossRef

Andresen D, Donaldson A, Choo L, Knox A, Klaassen M, Ursic C, Vonthethoff L, Krilis S, Konecny P. (2005). Multifocal cutaneous mucormycosis complicating polymicrobial wound infections in a tsunami survivor from Sri Lanka. Lancet. 365(9462):876-878CrossRef

Andrianaki AM, Kyrmizi I, Thanopoulou K, Baldin C, Drakos E, Soliman SS, Shetty AC, McCracken C, Akoumianaki T, Stylianou K, Ioannou P. (2018). Iron restriction inside macrophages regulates pulmonary host defense against Rhizopus species. Nat. Commun. 9(1):1-17

Augustine HF, White C, Bain J (2017). Aggressive combined medical and surgical management of mucormycosis results in disease eradication in 2 pediatric patients. Plast. Surg. 25(3):211-217.CrossRef

Badiane AS, Ndiaye D, Denning DW (2015). Burden of fungal infections in Senegal. Mycoses, 58:63-69.CrossRef

Baldin C, Ibrahim AS. (2017). Molecular mechanisms of mucormycosis—the bitter and the sweet. PLoS pathog. 13(8):1006408.CrossRef

Banerjee I, Robinson J, Asim M, Sathian B, Banerjee I. (2021). Mucormycosis and COVID-19 an epidemic in a pandemic? Nepal J. Epidemiology. 11(2):1034.CrossRef

Bellazreg F, Hattab Z, Meksi S, Mansouri S, Hachfi W, Kaabia N, Said MB, Letaief A. (2015). Outcome of mucormycosis after treatment: report of five cases. New microbes new infect. 6:49-52.CrossRef

Bhadauria D, Etta P, Chelappan A, Gurjar M, Kaul A, Sharma RK, Gupta A, Prasad N, Marak RS, Jain M, Srivastava A (2018). Isolated bilateral renal mucormycosis in apparently immunocompetent patients—a case series from India and review of the literature. Clin. Kidney J. 11(6):769-776.

Carolus H, Pierson S, Lagrou K, Van Dijck P. (2020) Amphotericin B and Other Polyenes—Discovery, Clinical Use, Mode of Action and Drug Resistance. J Fungi. 6(4):321.CrossRef

Carroll CS, Grieve CL, Murugathasan I, Bennet AJ, Czekster CM, Liu H, Naismith J, Moore MM. (2017). The rhizoferrin biosynthetic gene in the fungal pathogen Rhizopus delemar is a novel member of the NIS gene family. Int. J. Biochem. Cell. Bio. 89:136-146.CrossRef

Caza M, Kronstad J. (2013). Shared and distinct mechanisms of iron acquisition by bacterial and fungal pathogens of humans. Front. Cell. Infect. Microbiol. 3:80.CrossRef

Centers for Disease Control and Prevention www.cdc.gov/fungal/diseases/mucormycosis January 14, 2021 Accessed July 25th 2021

Chakrabarti A, Das A, Sharma A, Panda N, Das S, Gupta KL, Sakhuja V (2001) Ten Years’ Experience in Zygomycosis at a Tertiary Care Centre in India. J. Infect. 42:261–266CrossRef

Chakrabarti A, Das A, Mandal J, Shivaprakash MR, George VK, Tarai B, Rao P, Panda N, Verma SC, Sakhuja V (2006). The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med. Mycol. 44:335–342.CrossRef

Chakrabarti A, Chatterjee SS, Das A, Panda N, Shivaprakash MR, Kaur A, Varma SC, Singhi S, Bhansali A, Sakhuja V (2009). Invasive zygomycosis in India: Experience in a tertiary care hospital. Postgrad. Med. J. 85:573–581CrossRef

Challa S. (2019). Mucormycosis: Pathogenesis and pathology. Curr. Fungal Infect. Rep. 13(1):11-20.CrossRef

Chapman N, Doubell A, Oversteegen L, Chowdhary V, Rugarabamu G, Zanetti R, Ong M, Borri J. (2017). Neglected disease research and development: reflecting on a decade of global investment. Policy cures research.

Chen Q, Chen K, Qian S, Wu S, Xu L, Huang X, Shi P, Wang K, Wang M, Wang X. (2019) Disseminated mucormycosis with cerebellum involvement due to Rhizomucor pusillus in a patient with multiple myeloma and secondary myelodysplastic syndrome: A case report. Experimental and therapeutic medicine. 18(5):4076-80.

Dallalzadeh LO, Ozzello DJ, Liu CY, Kikkawa DO, Korn BS. (2021). Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19. Orbit. 25:1-4.

Daoud A, Elbendary A, Elfishawi M, Rabea M, Alfishawy M, (2014). Diabetic ketoacidosis with two life threatening infections: mucormycosis, and bilateral emphysematous pyelonepritis, preciptating erythema nodosum leprosum as the initial presentation of diabetes. Diabetes Metab J. 5(433):2.

Denning DW. (2002). Echinocandins: a new class of antifungal. J. Antimicrob. Chemother. 49(6):889-891.CrossRef

Dioverti MV, Cawcutt KA, Abidi M, Sohail MR, Walker RC, Osmon DR (2015). Gastrointestinal mucormycosis in immunocompromised hosts. Mycoses. 58(12):714-718.CrossRef

Eid R, Arab NT, Greenwood MT. (2017). Iron mediated toxicity and programmed cell death: A review and a re-examination of existing paradigms. Biochim Biophys Acta Mol Cell Res. 1864(2):399-430.CrossRef

El-Mahallawy HA, Khedr R, Taha H, Shalaby L, Mostafa A (2016). Investigation and management of a Rhizomucor outbreak in a pediatric cancer hospital in Egypt. Pediatr. Blood Cancer. 63(1):171-173.CrossRef

Fadhel M, Patel SV, Liu E, Fune L, Wasserman EJ, Asif A (2019). Disseminated pulmonary with isolated muscular mucormycosis in an acute myeloid leukemia patient: a case report and literature review. Am. J. Med. Case Rep. 20:1210.CrossRef

Fatima N, Javaid K, Lahmo K, Banday S, Sharma P, Masoodi, L. (2017). Siderophore in fungal physiology and virulence. Int. J. Res. Phytochem. Pharmacol. 6(5):1073-1080.

Feng J, Sun X (2018). Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome. Infection. 46(4):503-512.CrossRef

GAFFI. Global Fund for Fungal Infections. 2018. Available from: http://www.gaffi.org. Accessed 23 July 2021.

Garg D, Muthu V, Sehgal IS, Ramachandran R, Kaur H, Bhalla A, Puri GD, Chakrabarti A, Agarwal R. (2021). Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia. 186(2):289–298.CrossRef

Gerwien F, Skrahina V, Kasper L, Hube B, Brunke S. (2018). Metals in fungal virulence. FEMS Microbiol. Rev. 42(1):50.CrossRef

Govender NP, Chiller TM, Poonsamy B, Frean JA. (2011) Neglected fungal diseases in sub-Saharan Africa: A call to action. Curr Fungal Infect Rep. 5(4):224–32.CrossRef

Hartnett KP, Jackson BR, Perkins KM, Glowicz J, Kerins JL, Black SR, Lockhart SR, Christensen BE, Beer KD. (2019). A guide to investigating suspected outbreaks of mucormycosis in healthcare. J. Fungus. 5(3):69CrossRef

Hassan MIA, Voigt K. (2019). Pathogenicity patterns of mucormycosis: epidemiology, interaction with immune cells and virulence factors. Med. Mycol. J. 57(2):245-S256.CrossRef

He J, Sheng G, Yue H, Zhang F, Zhang HL. (2021). Isolated pulmonary mucormycosis in an immunocompetent patient: a case report and systematic review of the literature, BMC Pulm. Med. 21(1):1-8.CrossRef

Hsu LY, Ding Y, Phua J, Koh LP, Chan DS, Khoo KL, Tambyah, PA. (2010). Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients. BMJ Infect. Dis. 10(1):1-6. http://www.fda.gov/cder/approval/index.html Accessed 25 July 2021.

Huang H, Xie L, Zheng Z, Yu H, Tu L, Cui C, and Yu J. (2021). Mucormycosis-induced upper gastrointestinal ulcer perforation in immunocompetent patients: a report of two cases. BMC gastroenterol. 21(311):1-7.

Ibrahim AS, Gebremariam T, Lin L, Luo G, Husseiny MI, Skory CD, Fu Y, French SW, Edwards Jr JE, Spellberg B. (2010). The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis. Mol. Microbiol. 77(3):587-604CrossRef

Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis, DP (2012). Pathogenesis of mucormycosis. Clin. Infect. Dis. 54(1):16-22.CrossRef

Inglesfield S, Jasiulewicz A, Hopwood M., Tyrrell J, Youlden G, Mazon-Moya M, Millington OR, Mostowy S, Jabbari S, Voelz K. (2018). Robust phagocyte recruitment controls the opportunistic fungal pathogen Mucor circinelloides in innate granulomas in vivo. MBio. 9(2):10-17.CrossRef

International Diabetes Federation Idf diabetes atlas. 2019. https://diabetesatlas.org/en/resources/www.idf.org Accessed 25 July 2021.

Jennessen J, Nielsen KF, Houbraken J, Lyhne EK, Schnürer J, Frisvad JC, Samson RA. (2005). Secondary metabolite and mycotoxin production by the Rhizopus microsporus group. J. Agric. Food Chem. 53(5):1833-1840.CrossRef

Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, Chen, S. A. (2019). The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin. Microbiol. Infect. 25(1):26-34.

Jose A, Singh S, Roychoudhury A, Kholakiya Y, Arya S, Roychoudhury S. (2021). Current Understanding in the Pathophysiology of SARS-CoV-2-Associated Rhino-Orbito-Cerebral Mucormycosis: A Comprehensive Review. J. Oral Maxillofac. Surg. 20:373-380.CrossRef

Kaur H, Ghosh A, Rudramurthy SM, Chakrabarti A (2018). Gastrointestinal mucormycosis in apparently immunocompetent hosts—A review. Mycoses. 61(12):898-908.CrossRef

Khaba MC, Nevondo LM, Moroatshehla SM, Makhado NA (2021). Disseminated mucormycosis presenting as a renal mass in a human immunodeficiency virus-infected patient: A case report. S Afr. J. Infect D. 36(1):4.

Koehler P, Cornely OA, Böttiger BW, Dusse F, Eichenauer DA, Fuchs F, Hallek M, Jung N, Klein F, Persigehl T, Rybniker J. (2020). COVID-19 associated pulmonary aspergillosis. Mycoses. 63(6):528-534.CrossRef

Kontoyiannis DP, Yang H, Song J, Kelkar SS, Yang X, Azie N, Harrington R, Fan A, Lee E, Spalding J. R. (2016). Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study. BMC Infect. Dis. 16:730

Kornitzer D, Roy U. (2020). Pathways of heme utilization in fungi. Biochim Biophys Acta Mol Cell Res. 1867(11):118817CrossRef

Lackner G, Hertweck C. (2011). Impact of endofungal bacteria on infection biology, food safety, and drug development. PLoS pathog. 7(6):1002096.CrossRef

Lamoth F, Kontoyiannis DP. (2018). The Candida auris alert: facts and perspectives. J. Infect. Dis. 217(4):516-520.CrossRef

Laniado-Laborín R, Cabrales-Vargas MN. (2009). Amphotericin B: side effects and toxicity. Rev. Iberoam. Micol. 26(4):223-227.CrossRef

Lanternier F, Dannaoui E, Morizot G, Elie C, Garcia-Hermoso D, Huerre M, Bitar D, Dromer F, & Lortholary O (2012). The French Mycosis Study Group. A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005–2007). Clin. Infect. Dis. 54:35–43.CrossRef

Li H, Liu SM, Yu XH, Tang SL, Tang CK (2020). Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int. J. Antimicrob. Agents 55(5):105951.CrossRef

Luo Y, Li J, Zhou H, Yu B, He J, Wu A, Huang Z, Zheng P, Mao X, Yu J, Li H. (2021). The Nutritional Significance of Intestinal Fungi: Alteration of Dietary Carbohydrate Composition Triggers Colonic Fungal Community Shifts in a Pig Model. Appl. Environ. Microbiol. 87(10):38-21.CrossRef

Maital S, Barzani E (2020). The global economic impact of COVID-19: A summary of research. Samuel Neaman Institute for National Policy Research, 2020, 1-12.

Mandengue CE, Denning DW (2018). The burden of serious fungal infections in Cameroon. J. Fungus. 4(2):44.CrossRef

Michel C, Cabanac M. (2016). Effects of Dexamethasone on the Body Weight Set-Point of Rats. Physiol. Behav. 60:817-821.

Mihu MR, Pattabhi R, Nosanchuk JD. (2014). The impact of antifungals on toll-like receptors. Front. Microbiol. 5:99.CrossRef

Morales-Franco B, Nava-Villalba M, Medina-Guerrero EO, Sánchez-Nuño YA, Davila-Villa P, Anaya-Ambriz EJ, Charles-Niño CL. (2021). Host-Pathogen Molecular Factors Contribute to the Pathogenesis of Rhizopus spp. in Diabetes Mellitus. Curr. Trop. Med. Rep. 8:6–17CrossRef

Neblett Fanfair R, Benedict K, Bos J, Bennett SD, Lo YC, Adebanjo T, Etienne K, Deak E, Derado G, Shieh WJ, Drew C. (2012). Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N. Engl. J. Med. 367(23):2214-2225.CrossRef

Oladeji SM, Amusa YB, Olabanji JK, Adisa AO (2013). Rhinocerebral mucormycosis in a diabetic case report. J West Afr. Coll. Surg. 3(1):93-102

Onyango JF, Kayima JK, Owen WO (2002). Rhinocerebral mucormycosis: case report. East Afr. Med. J. 79(7):390-393.CrossRef

Paduraru M, Moreno-Sanz C, Gallardo JMO. (2016). Primary cutaneous mucormycosis in an immunocompetent patient. Case Reports, 2016, p. bcr2016214982.

Pal R, Singh B, Bhadada SK, Banerjee M, Bhogal RS, Hage N, Kumar A. (2021). COVID-19-associated mucormycosis: An updated systematic review of literature. Mycoses. 00:1– 8

Palermo NE, Sadhu AR, McDonnell ME. (2020). Diabetic ketoacidosis in COVID-19: unique concerns and considerations. J. Clin. Endocrinol. Metab. 105(8):2819-2829.CrossRef

Pan American Health Organization / World Health Organization. Epidemiological Alert: COVID-19 associated Mucormycosis. June 2021, Washington, D.C.: PAHO/WHO; 2021 Accessed 30 July 2021.

Petrikkos G, Tsioutis C. (2018). Recent advances in the pathogenesis of mucormycoses. Clin. ther. 40(6):894-902.CrossRef

Pianalto KM., Alspaugh JA. (2016). New horizons in antifungal therapy. J. Fungus. 2(4):26.CrossRef

Prakash H, Chakrabarti A (2019). Global epidemiology of mucormycosis. J. Fungus. 5(1):26.

Prakash H, Chakrabarti A (2021). Epidemiology of mucormycosis in India. Microorganisms. 9(3):523.

Prakash H, Ghosh AK, Rudramurthy SM, Singh P, Xess I, Savio J, Pamidimukkala U, Jillwin J, Varma S, Das A, Panda NK (2019). A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment. Med. Mycol. J. 57(4):395-402.CrossRef

Ramadorai A, Ravi P, Narayanan V (2019). Rhinocerebral mucormycosis: A prospective analysis of an effective treatment protocol Ann. Maxillofac. Surg. 9(1):192.CrossRef

Ramamoorthy S, Cidlowski JA. (2016). Corticosteroids: mechanisms of action in health and disease. Rheum. Dis. Clin. 42(1):15-31.CrossRef

Ramaswami A, Sahu AK, Kumar A, Suresh S, Nair A, Gupta D, Chouhan R, Bhat R, Mathew R, Aggarwal P, Nayer J. (2021). COVID-19 associated Mucormycosis Presenting to the Emergency Department–An Observational Study of 70 Patients. QJM: An International Journal of Medicine.

Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. (1998). The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. Clin. Infect. Dis. 27(5):1138–1147.CrossRef

Richardson K, Cooper K, Marriott MS, Tarbit MH., Troke F, Whittle PJ. (1990). Discovery of fluconazole, a novel antifungal agent. Rev. Infect. Dis. 12(3):267-271.CrossRef

Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis, DP. (2005). Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin. Infect. Dis. 41(5):634-653.CrossRef

Rodrigues ML, Albuquerque PC (2018). Searching for a change: The need for increased support for public health and research on fungal diseases. PLOS Negl. Trop. Dis. 12(6):0006479.CrossRef

Rodrigues ML, Nosanchuk JD. (2020). Fungal diseases as neglected pathogens: A wake-up call to public health officials. PLOS Negl. Trop. Dis. 14(2):0007964.CrossRef

Saegeman V, Maertens J, Meersseman W, Spriet I, Verbeken E, Lagrou K (2010). Increasing incidence of mucormycosis in University Hospital, Belgium. Emerg. Infect. Dis. 16(9):1456.CrossRef

Sahoo NK, Kulkarni V, Bhandari AK, Kumar A. (2017). Mucormycosis of the frontal sinus: A rare case report and review. Ann. Maxillofac. Surg. 7(1):120.

Sánchez-Gil J, Guirao-Arrabal E, Parra-García GD, del Pilar Luzón-García M, Bautista-Marín MF, Barayobre-Barayobre M, Fontalba-Navas A. (2017). Nosocomial rhinocerebral mucormycosis: two cases with a temporal relationship. Mycopathologia. 182(9):933-935.CrossRef

Saneesh PS, Yelamanchi R, Pilllai S. (2021). Isolated renal mucormycosis presenting with bilateral renal artery thrombosis: a case report. Afr. J. Urol. 27(1):1-4.CrossRef

Schwartz IS, Kenyon C, Lehloenya R, Claasens S, Spengane Z, Prozesky H, Burton R, Parker A, Wasserman S, Meintjes G, Mendelson M. (2017) AIDS-related endemic mycoses in Western Cape, South Africa, and clinical mimics: a cross-sectional study of adults with advanced HIV and recent-onset, widespread skin lesions. In Open forum infectious diseases US: Oxford University Press. 4(4):186.CrossRef

Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. (2021). Mucor in a viral land: a tale of two pathogens. Indian J. Ophthalmol. 69(2):244.CrossRef

Shanmugam S, Rajeshwari B, Niamath S, Ghosh M (2019). Isolated Renal Zygomycosis, A Rare and Lethal Cause of Massive Renal Infarction-Report of Two Cases. J. Clin. Diagnostic Res. 13(5):1-3.

Sharma S, Grover M, Bhargava S, Samdani S, Kataria T. (2021). Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. J Laryngol Otol. 135(5):442-447.CrossRef

Singh AK, Singh R, Joshi SR, Misra A. (2021) Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 15(4):102146.CrossRef

Skiada A, Lass-Floerl C, Klimko N, Ibrahim A, Roilides E, Petrikkos G (2018). Challenges in the diagnosis and treatment of mucormycosis. Med. mycol. 56(1):93-101.CrossRef

Skiada A, Pavleas I, Drogari-Apiranthitou M. (2020). Epidemiology and diagnosis of mucormycosis: an update. J. Fungus. 6(4):265.CrossRef

Stanford FA, Voigt K. (2020). Iron Assimilation during Emerging Infections Caused by Opportunistic Fungi with emphasis on Mucorales and the Development of Antifungal Resistance. Genes. 11(11):1296.CrossRef

Stemler J, Hamed K, Salmanton-García J, Rezaei-Matehkolaei A, Gräfe SK, Sal E, Zarrouk M, Seidel D, Abdelaziz Khedr R, Ben-Ami R, Ben-Chetrit E. (2020). Mucormycosis in the Middle East and North Africa: Analysis of the FungiScope® registry and cases from the literature. Mycoses. 63(10):1060-1068.CrossRef

Sterne JA, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, Annane D, Azevedo LCP, Berwanger O, Cavalcanti AB, Dequin PF. (2020). Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. Jama. 324(13):1330-1341.CrossRef

Sukaina M (2021). Re-emergence of mucormycosis in COVID-19 recovered patients transiting from silent threat to an epidemic in India. J. Glob. Health. 5:2021067.

Sundermann AJ, Clancy CJ, Pasculle AW, Liu G, Cumbie RB, Driscoll E, Ayres A, Donahue L, Pergam SA, Abbo L, Andes DR. (2019). How clean is the linen at my hospital? The Mucorales on unclean linen discovery study of large United States transplant and cancer centers. Clin. Infect. Dis. 68(5):850-853.CrossRef

Vaughan C, Bartolo A, Vallabh N, Leong SC (2018). A meta-analysis of survival factors in rhino-orbital-cerebral mucormycosis—has anything changed in the past 20 years? Clin Otolaryngol. 43(6):1454-1464.CrossRef

Walsh TJ, Gamaletsou MN, McGinnis MR, Hayden RT, Kontoyiannis DP. (2012). Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clin. Infect. Dis. 54(1):55-60.CrossRef

White JD, Blakemore PR, Green NJ, Hauser EB, Holoboski MA, Keown LE, Nylund Kolz CS, Phillips BW. (2002). Total Synthesis of Rhizoxin D, a Potent Antimitotic Agent from the Fungus Rhizopus chinensis. J. Org. Chem. 67(22):7750-7760.CrossRef

WHO. Coronavirus disease (COVID-19): Dexamethasone https://www.who.int/news-room/q-a-detail/coronavirus-disease-covid-19-dexamethasone Accessed August 3, 2021.

WHO. Fact sheet: Tuberculosis. http://www.who.int/mediacentre/factsheets/fs104/en/. 2018. Accessed 25 July 2021.

Wotiye AB, Poornachandra KS, Ayele BA. (2020). Invasive intestinal mucormycosis in a 40-year old immunocompetent patient-a rarely reported clinical phenomenon: a case report. BMC Gastroenterol. 20(61):1-6.

www.egyptindependent.com/mansoura-university-hospital-reports-black-fungus-cases/. Accessed 25 July 2021

www.scopus.com/search/form.uri?display=basic#basic Accessed August 5, 2021.

Yiannikourides A, Latunde-Dada GO. (2019). A short review of iron metabolism and pathophysiology of iron disorders. Medicines. 6(3):85.CrossRef

Youssef J, Novosad SA., Winthrop KL. (2016). Infection risk and safety of corticosteroid use. Rheum. Dis. Clin. 42(1):157-176.CrossRef

Yusuf EO, Onyiriuka AN (2012). Subcutaneous Mucormycosis in an Immunocompetent Nigerian Child. Turk. J. Med. Sci. 39(2):309-311.

Titel: Re-Emerging Systemic Mucormycosis Associated With COVID-19 Infection in Africa
verfasst von: Abimbola D. Akinyosoye
Paul A. Akinduti
Verlag: Springer International Publishing
Buch: Bioenergy and Biochemical Processing Technologies
Print ISBN: 978-3-030-96720-8

Electronic ISBN: 978-3-030-96721-5

Copyright-Jahr: 2022
DOI: https://doi.org/10.1007/978-3-030-96721-5_25